FDA Inspection 1304158 - Misemer Pharmaceutical - February 23, 2026

Record Details

This FDA Inspection record concerns Misemer Pharmaceutical, with an inspection on February 23, 2026, issued by the New Orleans District Office, covering human drugs.

Company: Misemer Pharmaceutical
Inspection Date: February 23, 2026
Product Type: Human Drugs
Office: New Orleans District Office

Open in Dashboard

ID · c4abaf4f-fd5f-47d3-b7de-450babb36521

Violation Codes3

21 CFR 314.80(b)21 CFR 314.80(c)(2)21 CFR 314.81(b)(2)

Full citation text and observation details available on the Dashboard.